Neuroendocrine Tumor Board 2023-2024

---

RSSCMECNESafetyPSRM - Patient Safety/Risk ManagementState Required CME

Occurs weekly every Friday starting on 1/27/2023 at 7:00 AM
Friday, January 27, 2023, 7:00 AM - 8:00 AM, Microsoft Teams, Philadelphia, PA

Neuroendocrine Tumor (NET) Board provides a forum for the presentation of neuroendocrine patient cases to a multidisciplinary team of care providers for the porpose of engaging in the process of shared decision-making to determine optimal, personalized treatment plans for NET patient / families. This forum also provides a platform for the dissemination and discussion of important topics in the field of neuroendocrinology, such as: (1) identifying newly approved treatments, imaging techniques, pharmaceuticals, etc and to determine how they may be incorporated into the case discussions, treatment algorithms and treatment plans for patients (2) Discussing clinical trials and new research studies open to neuroendocrine patients, and providing updates on current reach endeavors (3) Elucidating educational advances in the field of neuroendocrinology (4) Encouraging attendance at academic meetings, participation in academic research and announcing funding opportunities for NET research. The Neuroendocrine Tumor Board Meetings also: -Foster a sense of interprofessional collaboration within the multidisciplinary NET team, in the delivery of NET patient care. -Encourage academic and research endeavors amongst the NET multidisciplinary group. -Educate and mentor new members to the NET team of caregivers.

1. Discuss appropriate, comprehensive, multidisciplinary best practice treatment plans for NET patients and their families
2. Describe an in-depth knowledge of the various imaging techniques and treatment options for the diagnosis, surveillance and treatment of NET patient.
3. Discuss the rapidly evolving field of neuroendocrinology through analysis of best medical practices and research
4. Discuss how to strengthen professionalism among the multidisciplinary team participants

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

Designation of Credit
Physicians: Penn Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance / Participation (1.00 hours), NCPD Hours (ANCC) (1.00 hours), Patient Safety/Risk Management PSRM (1.00 hours)

Mitigation of Relevant Financial Relationships

Penn Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

No faculty are available for this activity at this time.

Date	Empty Column	Title
4/7/2023 7:00:00 AM	Neuroendocrine Tumor Board 2023-2024 - 4/7/2023 4/7/2023 7:00:00 AM 4/7/2023 8:00:00 AM 15 Microsoft Teams False MM/DD/YYYY	Neuroendocrine Tumor Board 2023-2024 - 4/7/2023 Neuroendocrine Tumor (NET) Board provides a forum for the presentation of neuroendocrine patient cases to a multidisciplinary team of care providers for the porpose of engaging in the process of shared decision-making to determine optimal, personalized treatment plans for NET patient / families. This forum also provides a platform for the dissemination and discussion of important topics in the field of neuroendocrinology, such as: (1) identifying newly approved treatments, imaging techniques, pharmaceuticals, etc and to determine how they may be incorporated into the case discussions, treatment algorithms and treatment plans for patients (2) Discussing clinical trials and new research studies open to neuroendocrine patients, and providing updates on current reach endeavors (3) Elucidating educational advances in the field of neuroendocrinology (4) Encouraging attendance at academic meetings, participation in academic research and announcing funding opportunities for NET research. The Neuroendocrine Tumor Board Meetings also: -Foster a sense of interprofessional collaboration within the multidisciplinary NET team, in the delivery of NET patient care. -Encourage academic and research endeavors amongst the NET multidisciplinary group. -Educate and mentor new members to the NET team of caregivers. Objective(s): Location: Microsoft Teams Specialties: DERMATOLOGY, FAMILY MEDICINE, PEDIATRICS, INTERNAL MEDICINE - Advanced Heart Failure and Transplant Cardiology, INTERVENTIONAL RADIOLOGY AND DIAGNOSTIC RADIOLOGY, NUCLEAR MEDICINE, INTERNAL MEDICINE - Medical Oncology, PATHOLOGY - CLINICAL, PSYCHIATRY, RADIATION ONCOLOGY, SURGERY, THORACIC AND CARDIAC SURGERY, UROLOGY, VASCULAR SURGERY, INTERNAL MEDICINE - Endocrinology, Diabetes and Metabolism, INTERNAL MEDICINE - Gastroenterology, INTERNAL MEDICINE, INTERNAL MEDICINE - Geriatric Medicine, INTERNAL MEDICINE - Nephrology, OTOLARYNGOLOGY, INTERNAL MEDICINE - Adult Congenital Heart Disease, INTERNAL MEDICINE - Cardiovascular Disease, PATHOLOGY - ANATOMIC, MEDICAL GENETICS AND GENOMICS - Medical Biochemical Genetics, LABORATORY GENETICS AND GENOMICS, MEDICAL GENETICS AND GENOMICS - Molecular Genetic Pathology, OTOLARYNGOLOGY - Neurotology, PEDIATRICS - Pediatric Gastroenterology, PEDIATRICS - Pediatric Hematology-Oncology, PEDIATRICS - Pediatric Nephrology, INTERNAL MEDICINE - Hospice and Palliative Medicine, RADIOLOGY , RADIOLOGY - Nuclear Radiology, RADIOLOGY - Pain Medicine, SURGERY - Complex General Surgical Oncology, SURGERY - Pediatric Surgery, PATHOLOGY-ANATOMIC/PATHOLOGY-CLINICAL Faculty Disclosures: Maria Bonanni, CRNP (Nothing to disclose - 05/10/2022) Debbie Cohen, MD (Nothing to disclose - 02/17/2023) Download Handout Credits: AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance / Participation (1.00 hours), NCPD Hours (ANCC) (1.00 hours), Patient Safety/Risk Management PSRM (1.00 hours) Location: Microsoft Teams Specialties: DERMATOLOGY, FAMILY MEDICINE, PEDIATRICS, INTERNAL MEDICINE - Advanced Heart Failure and Transplant Cardiology, INTERVENTIONAL RADIOLOGY AND DIAGNOSTIC RADIOLOGY, NUCLEAR MEDICINE, INTERNAL MEDICINE - Medical Oncology, PATHOLOGY - CLINICAL, PSYCHIATRY, RADIATION ONCOLOGY, SURGERY, THORACIC AND CARDIAC SURGERY, UROLOGY, VASCULAR SURGERY, INTERNAL MEDICINE - Endocrinology, Diabetes and Metabolism, INTERNAL MEDICINE - Gastroenterology, INTERNAL MEDICINE, INTERNAL MEDICINE - Geriatric Medicine, INTERNAL MEDICINE - Nephrology, OTOLARYNGOLOGY, INTERNAL MEDICINE - Adult Congenital Heart Disease, INTERNAL MEDICINE - Cardiovascular Disease, PATHOLOGY - ANATOMIC, MEDICAL GENETICS AND GENOMICS - Medical Biochemical Genetics, LABORATORY GENETICS AND GENOMICS, MEDICAL GENETICS AND GENOMICS - Molecular Genetic Pathology, OTOLARYNGOLOGY - Neurotology, PEDIATRICS - Pediatric Gastroenterology, PEDIATRICS - Pediatric Hematology-Oncology, PEDIATRICS - Pediatric Nephrology, INTERNAL MEDICINE - Hospice and Palliative Medicine, RADIOLOGY , RADIOLOGY - Nuclear Radiology, RADIOLOGY - Pain Medicine, SURGERY - Complex General Surgical Oncology, SURGERY - Pediatric Surgery, PATHOLOGY-ANATOMIC/PATHOLOGY-CLINICAL
4/14/2023 7:00:00 AM	Neuroendocrine Tumor Board 2023-2024 - 4/14/2023 4/14/2023 7:00:00 AM 4/14/2023 8:00:00 AM 15 Microsoft Teams False MM/DD/YYYY	Neuroendocrine Tumor Board 2023-2024 - 4/14/2023 Neuroendocrine Tumor (NET) Board provides a forum for the presentation of neuroendocrine patient cases to a multidisciplinary team of care providers for the porpose of engaging in the process of shared decision-making to determine optimal, personalized treatment plans for NET patient / families. This forum also provides a platform for the dissemination and discussion of important topics in the field of neuroendocrinology, such as: (1) identifying newly approved treatments, imaging techniques, pharmaceuticals, etc and to determine how they may be incorporated into the case discussions, treatment algorithms and treatment plans for patients (2) Discussing clinical trials and new research studies open to neuroendocrine patients, and providing updates on current reach endeavors (3) Elucidating educational advances in the field of neuroendocrinology (4) Encouraging attendance at academic meetings, participation in academic research and announcing funding opportunities for NET research. The Neuroendocrine Tumor Board Meetings also: -Foster a sense of interprofessional collaboration within the multidisciplinary NET team, in the delivery of NET patient care. -Encourage academic and research endeavors amongst the NET multidisciplinary group. -Educate and mentor new members to the NET team of caregivers. Objective(s): Location: Microsoft Teams Specialties: DERMATOLOGY, FAMILY MEDICINE, PEDIATRICS, INTERNAL MEDICINE - Advanced Heart Failure and Transplant Cardiology, INTERVENTIONAL RADIOLOGY AND DIAGNOSTIC RADIOLOGY, NUCLEAR MEDICINE, INTERNAL MEDICINE - Medical Oncology, PATHOLOGY - CLINICAL, PSYCHIATRY, RADIATION ONCOLOGY, SURGERY, THORACIC AND CARDIAC SURGERY, UROLOGY, VASCULAR SURGERY, INTERNAL MEDICINE - Endocrinology, Diabetes and Metabolism, INTERNAL MEDICINE - Gastroenterology, INTERNAL MEDICINE, INTERNAL MEDICINE - Geriatric Medicine, INTERNAL MEDICINE - Nephrology, OTOLARYNGOLOGY, INTERNAL MEDICINE - Adult Congenital Heart Disease, INTERNAL MEDICINE - Cardiovascular Disease, PATHOLOGY - ANATOMIC, MEDICAL GENETICS AND GENOMICS - Medical Biochemical Genetics, LABORATORY GENETICS AND GENOMICS, MEDICAL GENETICS AND GENOMICS - Molecular Genetic Pathology, OTOLARYNGOLOGY - Neurotology, PEDIATRICS - Pediatric Gastroenterology, PEDIATRICS - Pediatric Hematology-Oncology, PEDIATRICS - Pediatric Nephrology, INTERNAL MEDICINE - Hospice and Palliative Medicine, RADIOLOGY , RADIOLOGY - Nuclear Radiology, RADIOLOGY - Pain Medicine, SURGERY - Complex General Surgical Oncology, SURGERY - Pediatric Surgery, PATHOLOGY-ANATOMIC/PATHOLOGY-CLINICAL Faculty Disclosures: Bonita J. Bennett, BSN (Nothing to disclose - 11/22/2022) Maria Bonanni, CRNP (Nothing to disclose - 05/10/2022) Download Handout Credits: AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance / Participation (1.00 hours), NCPD Hours (ANCC) (1.00 hours), Patient Safety/Risk Management PSRM (1.00 hours) Location: Microsoft Teams Specialties: DERMATOLOGY, FAMILY MEDICINE, PEDIATRICS, INTERNAL MEDICINE - Advanced Heart Failure and Transplant Cardiology, INTERVENTIONAL RADIOLOGY AND DIAGNOSTIC RADIOLOGY, NUCLEAR MEDICINE, INTERNAL MEDICINE - Medical Oncology, PATHOLOGY - CLINICAL, PSYCHIATRY, RADIATION ONCOLOGY, SURGERY, THORACIC AND CARDIAC SURGERY, UROLOGY, VASCULAR SURGERY, INTERNAL MEDICINE - Endocrinology, Diabetes and Metabolism, INTERNAL MEDICINE - Gastroenterology, INTERNAL MEDICINE, INTERNAL MEDICINE - Geriatric Medicine, INTERNAL MEDICINE - Nephrology, OTOLARYNGOLOGY, INTERNAL MEDICINE - Adult Congenital Heart Disease, INTERNAL MEDICINE - Cardiovascular Disease, PATHOLOGY - ANATOMIC, MEDICAL GENETICS AND GENOMICS - Medical Biochemical Genetics, LABORATORY GENETICS AND GENOMICS, MEDICAL GENETICS AND GENOMICS - Molecular Genetic Pathology, OTOLARYNGOLOGY - Neurotology, PEDIATRICS - Pediatric Gastroenterology, PEDIATRICS - Pediatric Hematology-Oncology, PEDIATRICS - Pediatric Nephrology, INTERNAL MEDICINE - Hospice and Palliative Medicine, RADIOLOGY , RADIOLOGY - Nuclear Radiology, RADIOLOGY - Pain Medicine, SURGERY - Complex General Surgical Oncology, SURGERY - Pediatric Surgery, PATHOLOGY-ANATOMIC/PATHOLOGY-CLINICAL